High expression of SUMO2 protein was found to be closely associated with lymph node metastasis (85.3%) and vascular invasion (87.5%), with a high mortality rate (82.0%), but was not significantly correlated with other clinicopathological features (Table 6). The gene discussed is SUMO2; the disease is metastatic malignant neoplasm in the lymph nodes.